BioCryst Pharmaceuticals ... (BCRX)
BioCryst Pharmaceuticals Max Pain By Strike
BCRX trades at $8.37, 4.6% above the near-term max pain of $8 expiring Aug 15, 2025 (-1 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($1-$10), signaling increased put positioning or downside protection. Key magnetic zone at 8 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
BioCryst Pharmaceuticals Max Pain By Expiry
Max pain for BCRX shows a downward trend from 10 to 1, indicating bearish sentiment or hedging activity. The 131% spread signals divergent expectations across timeframes. Most levels below 8.37 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 8 | -0.37 (-4.36%) |
| Sep 19, 2025 | 8 | -0.37 (-4.36%) |
| Oct 17, 2025 | 1 | -7.37 (-88.05%) |
| Dec 19, 2025 | 9 | 0.63 (7.59%) |
| Jan 16, 2026 | 7 | -1.37 (-16.32%) |
| Mar 20, 2026 | 10 | 1.63 (19.55%) |
| Jan 15, 2027 | 5 | -3.37 (-40.23%) |